title: Picornavirus non-structural proteins as targets for new anti-virals with broad activity.
abstract: Picornaviridae is one of the largest viral families and is composed of 14 genera, six of which include human pathogens. The best known picornaviruses are enteroviruses (including polio, PV, and rhinoviruses), foot-and-mouth disease virus (FMDV), and hepatitis A virus (HAV). Although infections often are mild, certain strains may cause pandemic outbreaks accompanied with meningitis and/or paralysis. Vaccines are available for PV, HAV and FMDV. When the oral vaccines are given to immunocompromised individuals, they may be chronically infected, and remain secretors of vaccine-derived variants of virus for years. There is no effective prophylaxis available for these or other picornaviruses. So far, only the 3C protease from viruses in three genera has been fully characterized as an anti-viral target, whereas the mode of action of compounds targeting other non-structural proteins have remained largely unaddressed. Within the EU-supported FP6 project-VIZIER (Comparative Structural Genomics of Viral Enzymes Involved in Replication), the non-structural proteins were studied to identify conserved binding sites for broadly reactive anti-virals. The putative 2C helicase from echovirus-30 was shown to form ring-shaped hexamers typical for DNA-encoded SF3 helicases, and to possess ATPase activity. Hexamer formation of 2C from enterovirus 76 was in vitro shown to be dependent on the 44 N-terminal residues. Crystal structures of three enterovirus 3C proteases were solved and shown to be similar to those of other picornaviruses. A new binding site of VPg to the bottom of the thumb domain of CV-B3 3D polymerase was identified as a potential target. Broad anti-enterovirus compounds against 2C and 3A proteins were also identified, including thiazolobenzimidazoles (active against 2C) and TTP-8307 (targeting 3A). There is a need for more potent inhibitors against PV and other picornaviruses, which are potential silent reservoirs for re-emerging PV-like disease.
authors.affiliation: Virology Department, Swedish Institute for Infectious Disease Control, Solna, Sweden. helene.norder@smi.se
authors.forename: Heléne
authors.initials: H
authors.lastname: Norder
authors.forename: Armando M
authors.initials: AM
authors.lastname: De Palma
authors.forename: Barbara
authors.initials: B
authors.lastname: Selisko
authors.forename: Lionel
authors.initials: L
authors.lastname: Costenaro
authors.forename: Nicolas
authors.initials: N
authors.lastname: Papageorgiou
authors.forename: Carme
authors.initials: C
authors.lastname: Arnan
authors.forename: Bruno
authors.initials: B
authors.lastname: Coutard
authors.forename: Violaine
authors.initials: V
authors.lastname: Lantez
authors.forename: Xavier
authors.initials: X
authors.lastname: De Lamballerie
authors.forename: Cécile
authors.initials: C
authors.lastname: Baronti
authors.forename: Maria
authors.initials: M
authors.lastname: Solà
authors.forename: Jinzhi
authors.initials: J
authors.lastname: Tan
authors.forename: Johan
authors.initials: J
authors.lastname: Neyts
authors.forename: Bruno
authors.initials: B
authors.lastname: Canard
authors.forename: Miquel
authors.initials: M
authors.lastname: Coll
authors.forename: Alexander E
authors.initials: AE
authors.lastname: Gorbalenya
authors.forename: Rolf
authors.initials: R
authors.lastname: Hilgenfeld
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D006801:Humans; D010802:Phylogeny; D010849:Picornaviridae / Q000187:drug effects*; D020836:Protein Structure, Quaternary; D017386:Sequence Homology, Amino Acid; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry
chemical_list: D000998:Antiviral Agents; D017361:Viral Nonstructural Proteins